Follow the Lotus Eye Hospital and Institute Limited share price and the full management transaction log of the company, a publicly traded company based in India. Shares are quoted on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Lotus Eye Hospital and Institute Limited has logged 8 insider filings. Market capitalisation: €2.4bn. The latest transaction was disclosed on 6 July 2024 (Sale). Among the most active insiders: S Rajkumar. The full history is free.
8
Insider Decl.
n/a
Thresholds
€40,170
2 ops.
Buy Volume
€2m
4 ops.
Sell Volume
8Σ signal
Buys €40,170€2m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,049 of 29,065 companies
28.6
score / 100
Value
19
Quality
38
FCF yld-4.1%
Earn yld0.0%
EV/EBITDA57.1x
ROE0.1%
Gross mgn49%
Net mgn0.1%
Debt/EBITDA3.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.